See every side of every news story
Published loading...Updated

Federal Appellate court upholds DEA’s denial of Dr Sunil Aggarwal’s wish to provide psilocybin to his patients with late-stage and terminal cancer - Cannabis News World

Summary by Cannabis News World
A federal appellate court has upheld the Drug Enforcement Administration’s denial of a Seattle doctor’s request to use psilocybin, the active ingredient in magic mushrooms, to treat terminally ill cancer patients. Dr. Sunil Aggarwal, co-director of the Advanced Integrative Medical Science Institute, had sought approval from the DEA to provide psilocybin to his patients with
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Cannabis News World broke the news in on Saturday, February 22, 2025.
Sources are mostly out of (0)